Wednesday 24 Apr 2024
By
main news image
This article first appeared in The Edge Financial Daily, on October 4, 2016.

 

Asia Bioenergy Technologies Bhd (+ve)

SHARES in Asia Bioenergy Technologies Bhd (AsiaBio) (fundamental: 0.6/3, valuation: 0.3/3) triggered our momentum algorithm for the first time in September, after trades of 18.29 million shares, compared with its 200-day average volume of 1.44 million shares. The counter closed unchanged at five sen.

AsiaBio in August announced its performance for the first quarter ended June 30, 2016, reporting a lower net loss of RM7.68 million, compared with its net loss of RM10.18 million in the previous year.

Revenue for the quarter dropped 77% to RM1.51 million, from RM6.47 million in the previous year.

The loss for the quarter was attributed to the marking-to-market of its medium- to long-term investments, which was impacted by the poor performance of the stock market.

The counter trades at 1.3 times net asset value. The company did not pay out dividends in the financial year ended March 31, 2016.

      Print
      Text Size
      Share